CASTLE BIOSCIENCES INC Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Castle Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Castle Biosciences Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $5.08M.
  • Castle Biosciences Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.04M, a 98.8% increase year-over-year.
  • Castle Biosciences Inc annual Operating Income (Loss) for 2023 was -$68M, a 6.7% increase from 2022.
  • Castle Biosciences Inc annual Operating Income (Loss) for 2022 was -$72.9M, a 81.8% decline from 2021.
  • Castle Biosciences Inc annual Operating Income (Loss) for 2021 was -$40.1M, a 513% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$68M +$4.88M +6.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$72.9M -$32.8M -81.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$40.1M -$33.5M -513% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$6.54M -$13.9M -189% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $7.33M +$11.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$3.84M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.